About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Royal Bank of Canada (NY:RY)

165.39 +0.94 (+0.57%)

Official Closing Price Updated: 4:10 PM EDT, Apr 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Royal Bank of Canada

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

45 46 Next >

Are Hospital Stocks At Risk Amid Medicaid Funding Fears? RBC Downplays Worries While Retail Eyes Q1 Results ↗

April 22, 2025

The Wall Street Journal highlighted UHS, THC and HCA as key beneficiaries of Medicaid supplemental payment programs that cost the federal government hundreds of billions.

Via Stocktwits

Topics Government

Chipotle Mexican Grill Q1 Preview: Retail Gets Bullish As Traders Eye Tariff Commentary, Expansion Plans ↗

April 22, 2025

The burrito chain has maintained that it will not increase the prices of its menu items and will offset higher input costs through automation and other initiatives.

Via Stocktwits

Topics World Trade

Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost ↗

April 21, 2025

The new FDA commissioner had a few key ideas for the agency in an interview with Megyn Kelly.

Via Investor's Business Daily

Topics Government

American Express' Solid Revenue, Spending Trends Drive Analyst Optimism ↗

April 21, 2025

RBC analyst maintains Outperform rating on American Express (AXP) with $310 price target. AXP reports strong Q1 2025 results, reaffirms revenue and EPS outlook.

Via Benzinga

Looking Into RBC Bearings's Recent Short Interest ↗

April 16, 2025

Via Benzinga

3 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade ↗

April 15, 2025

Consider buying these top-notch AI-powered stocks in the current market dip.

Via The Motley Fool

Topics Artificial Intelligence

Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With It ↗

April 14, 2025

The companies are facing off with their heart drugs in a growing disease area.

Via Investor's Business Daily

We Asked Retail Traders Where Tesla's Next 20% Move Is — Most Say ‘Higher’ Despite Growing Short Interest ↗

April 14, 2025

Optimists think a bad earnings report is already priced in and hope CEO Elon Musk will soon announce his exit from Trump’s administration.

Via Stocktwits

Topics Bankruptcy Electric Vehicles Government

Canadian Banks Ranking 2025 – Which Bank To Hold? ↗

April 12, 2025

Whether you already hold one of these financial giants or are considering adding a bank to your portfolio, this will help you understand key strengths, weaknesses, and long-term investment potential.

Via Talk Markets

Topics Stocks / Equities

Energy Transfer: Tariff-Resistant Midstream Resilience

April 11, 2025

Energy Transfer showcases potential for investors through its record financial achievements, distribution yield, and strategic diversification efforts.

Via MarketBeat

Topics World Trade

Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks. ↗

April 10, 2025

From vaccines to fluoride and beef tallow, here's where Robert F. Kennedy Jr. is making changes to health care.

Via Investor's Business Daily

Topics Government

Wall Street Analysts Are Slashing Their Stock Market Forecasts. Here's What You Should Do, According to History. ↗

April 09, 2025

Via The Motley Fool

Topics Artificial Intelligence Economy Government

CorMedix Stock Rises After Preliminary Q1 Results Exceeds Expectations: Retail’s Elated ↗

April 08, 2025

The company expects quarterly adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) to exceed $22.5 million once final numbers are reported, exceeding expectations of $14.78...

Via Stocktwits

Pacira Biosciences Stock Rises On Patent Litigation Settlement: Retail Sentiment Soars ↗

April 08, 2025

RBC Capital opined that Pacira's settlement of litigation for generic Exparel, which provides some closure to over a year's worth of overhang and uncertainty for shares, is a win for the company and...

Via Stocktwits

Topics Intellectual Property

5 Consumer Stocks That Hit 52-Week Lows Last Week On Trump's Tariff Shockwaves ↗

April 07, 2025

Retailers and consumer-facing companies are reeling more prominently as they fear the potential hike to consumer prices of their products will directly hurt sales.

Via Stocktwits

Topics Economy Government Lawsuit

Woodside Energy In Spotlight After 40% Stake Sale In Louisiana LNG, Retail’s Bullish ↗

April 07, 2025

Stonepeak will provide $5.7 billion for the development of Louisiana LNG on an accelerated basis.

Via Stocktwits

Topics World Trade

Badger Meter Gets an Upgrade—2 Stocks That Could Follow

April 04, 2025

RBC analysts just boosted Badger Meter stock, but the broader theme behind this view might lead investors to other similar opportunities.

Via MarketBeat

Topics Economy Government World Trade

Chewy Stock Is About as Cheap as It's Ever Been. 1 Thing to Know Before You Buy. ↗

April 04, 2025

Via The Motley Fool

Topics Economy

BlackBerry's QNX, Secure Comms Growth Weighed Down By Tariff Uncertainties, Government Election Shifts: Analyst ↗

April 03, 2025

RBC Capital Markets analyst maintains BlackBerry with Sector Perform rating, lowers price target to $3.75 due to lower revenue and EBITDA guidance for fiscal 2026.

Via Benzinga

Sarepta Plunges After EMA Puts Gene Therapy Studies On Hold Following Teen's Death ↗

April 03, 2025

The holds are temporary while the teenager's death is under investigation.

Via Investor's Business Daily

Topics Death

Will the Stock Market Crash or Soar in 2025? Wall Street Analysts Are Changing Their Forecasts. ↗

April 03, 2025

Via The Motley Fool

Topics Economy Government

Enphase Energy Stock Declines After Jefferies Cuts Price Target Amid Demand Concerns: Retail Remains Bearish ↗

April 03, 2025

The brokerage highlighted that the outlook for residential demand for Enphase’s products remains challenged due to worsening sentiment with respect to the Inflation Reduction Act.

Via Stocktwits

Topics Artificial Intelligence Economy Government

Tesla (NQ:TSLA) Stock Drops on Q1 Vehicle Delivery Miss

April 02, 2025

April 2, 2025 – Tesla, Inc. (NQ:TSLA) shares fell sharply in morning trading today after the electric vehicle giant reported first-quarter vehicle deliveries that significantly undershot Wall Street...

Via MarketMinute

Topics Earnings Electric Vehicles

Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agencies ↗

April 02, 2025

The sector's recent slide follows Peter Marks' resignation last week as the Food and Drug Administration's top vaccine regulator following a clash with Kennedy.

Via Stocktwits

Topics ETFs Government

Bloom Energy Rises After Power Supply Agreement With Conagra, Fuels Retail Optimism ↗

April 02, 2025

The company’s fuel cells would supply about 70% to 75% of the electricity needs at two Conagra facilities.

Via Stocktwits

Topics Artificial Intelligence Emissions Government

Enphase Energy Stock Gains On Acquiring Over 2,500 SunPower Customers With Its Monitoring Services: Retail Remains Bearish ↗

April 01, 2025

Earlier, analysts at RBC Capital noted that while Enphase has a strong opportunity to return to growth eventually, in the near term, the company continues to cede market share amid softening demand.

Via Stocktwits

Topics Bankruptcy

Biotech Stocks Take Another Beating As 'Chaos' Reigns At FDA With Reports Of Mass Firings ↗

April 01, 2025

Reports of mass firings include another high-profile official as Robert F. Kennedy Jr. and Marty Makary take up their new roles.

Via Investor's Business Daily

Topics Workforce

Why Sarepta Therapeutics (SRPT) Stock Is Nosediving

March 31, 2025

Shares of biotech company Sarepta Therapeutics (NASDAQ:SRPT) fell 10.8% in the afternoon session after RBC analyst Brian Abrahams downgraded the stock from a Buy to a Hold rating and slashed the price...

Via StockStory

Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns ↗

March 31, 2025

Peter Marks heads up the department in charge of reviewing vaccines, genetic medicines and cell therapies.

Via Investor's Business Daily

Is RBC BEARINGS INC (NYSE:RBC) suited for quality investing? ↗

March 31, 2025

A fundamental analysis of (NYSE:RBC): Why Quality Investors Should Delve into RBC BEARINGS INC (NYSE:RBC) for Investment Opportunities.

Via Chartmill

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

45 46 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Royal Bank of Canada (NY:RY)

All News about Royal Bank of Canada

Sections

Services

Contact Information

Follow Us